Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 0 to 17

Using ultrasound with contrast to assess abdominal injuries in children

Official title: Contrast Enhanced Ultrasonography for Blunt Abdominal Trauma Imaging in Children

Run by Children's Hospital of Philadelphia · NCT03490929 · Data updated 2026-11-12

This study is testing if a special type of ultrasound can help find abdominal injuries in children with blunt trauma, instead of using a CT scan, to see if it’s a safer option.

Quick facts

PhasePhase 4
Study typeInterventional
Ages0 Years to 17 Years
SexAll
Enrollment146 (estimated)
SponsorChildren's Hospital of Philadelphia
Academic / other
Drugs / interventionsradiation
Locations2 sites (Rochester, Minnesota and 1 other locations)
StatusRecruiting
StartedJune 1, 2018
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedDecember 17, 2025
Trial IDNCT03490929 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are hemodynamically stable children aged 0-18 years with suspected blunt abdominal trauma.

Probably not a fit

Patients with a history of allergic reactions to the contrast agent or those with penetrating abdominal trauma may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of contrast enhanced ultrasound (CEUS) in detecting intra-abdominal organ injuries in children with blunt abdominal trauma, comparing its results to the conventional CT scan, which is currently the gold standard. The study aims to determine the sensitivity and specificity of CEUS, which could potentially reduce the need for CT scans, thereby minimizing radiation exposure and allowing for bedside evaluation. Participants will include hemodynamically stable children aged 0-18 years who have a history of or suspicion for blunt abdominal trauma and have an abdominal CT ordered. The study will utilize sulfur hexafluoride lipid microspheres as a contrast agent for the ultrasound procedure.

Why it matters

Potential benefit: If successful, this approach could provide a safer, radiation-free imaging alternative for children with abdominal trauma.

How similar studies have gone: Other studies have shown promise for contrast enhanced ultrasound in similar contexts, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Hemodynamically stable (defined as not needing massive transfusion protocol and not undergoing an emergent surgical procedure within the next hour)
2. History of or suspicion for blunt abdominal trauma
3. Abdominal CT ordered or obtained

Exclusion Criteria:

1. History of allergic reaction to Lumason, sulfur hexaflouride, sulfur hexafluoride lipid microsphere components, or other ingredients in Lumason (polyethylene glycol, distearoylphosphatidylcholine (DSPC), dipalmitoylphosphatidylglycerol sodium (DPPG-Na), palmitic acid)
2. Co-existing penetrating abdominal trauma
3. Known congenital or acquired heart disease

Where it's running

  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting
  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Aaron E Chen, MD — Children's Hospital of Philadelphia
  • Study coordinator: Aaron E Chen, MD
  • Email: chena2@chop.edu
  • Phone: 2674260383

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Using Ultrasound to Evaluate Abdominal Injuries in Children After Trauma

    This study is testing if a quick ultrasound can help doctors check for abdominal injuries in children after trauma, so they can avoid using CT scans that expose them to radiation.

    Recruiting at 6 sites University of California, Davis · Sacramento, California and 5 other locations · NCT05910567

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.